Seres Therapeutics, Inc.
- MCRB
- NASDAQ
- Biotechnology
- Microbiome Therapeutics
- Bacterial-Based Drugs
$2.46
Today −2.77%Quote Oct 16, 2026, 08:00 PM UTC
−40.00%over the last month
Max drawdown −41.0%From 1-month high −40.0%3 months −51.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$24.5M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$12.00
+387.8% from here
Floor
$2.42
1.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MCRBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
66